Literature DB >> 23808323

Novel monodisperse PEGtide dendrons: design, fabrication, and evaluation of mannose receptor-mediated macrophage targeting.

Jieming Gao, Peiming Chen, Yashveer Singh, Xiaoping Zhang, Zoltan Szekely, Stanley Stein, Patrick J Sinko.   

Abstract

Novel PEGtide dendrons of generations 1 through 5 (G1.0–5.0) containing alternating discrete poly(ethylene glycol) (dPEG) and amino acid/peptide moieties were designed and developed. To demonstrate their targeting utility as nanocarriers, PEGtide dendrons functionalized with mannose residues were developed and evaluated for macrophage targeting. PEGtide dendrons were synthesized using 9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase peptide synthesis (SPPS) protocols. The N-α-Fmoc-N-ε-(5-carboxyfluorescein)-l-lysine (Fmoc-Lys(5-FAM)-OH) and monodisperse Fmoc-dPEG6-OH were sequentially coupled to Fmoc-β-Ala-resin to obtain the resin-bound intermediate Fmoc-dPEG6-Lys(5-FAM)-β-Ala (1). G1.0 dendrons were obtained by sequentially coupling Fmoc-Lys(Fmoc)-OH, Fmoc-β-Ala-OH, and Fmoc-dPEG6-OH to 1. Dendrons of higher generation, G2.0–5.0, were obtained by repeating the coupling cycles used for the synthesis of G1.0. Dendrons containing eight mannose residues (G3.0-mannose8) were developed for mannose receptor (MR) mediated macrophage targeting by conjugating α-d-mannopyranosylphenyl isothiocyanate to G3.0 dendrons. In the present study PEGtide dendrons up to G5.0 were synthesized. The molecular weights of the dendrons determined by MALDI-TOF were in agreement with calculated values. The hydrodynamic diameters measured using dynamic light scattering (DLS) ranged from 1 to 8 nm. Cell viability in the presence of G3.0 and G3.0-mannose8 was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and was found to be statistically indistinguishable from that of untreated cells. G3.0-mannose8 exhibited 12-fold higher uptake than unmodified G3.0 control dendrons in MR-expressing J774.E murine macrophage-like cells. Uptake was nearly completely inhibited in the presence of 10 mg/mL mannan, a mannose analogue and known MR substrate. Confocal microscopy studies demonstrated the presence of significant intracellular punctate fluorescence colocalized with a fluid endocytosis marker with little surface fluorescence in cells incubated with G3.0-mannose8. No significant cell-associated fluorescence was observed in cells incubated with G3.0 dendrons that did not contain the targeting ligand mannose. The current studies suggest that PEGtide dendrons could be useful as nanocarriers in drug delivery and imaging applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23808323      PMCID: PMC3940669          DOI: 10.1021/bc400011v

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  45 in total

1.  "Cascade-release dendrimers" liberate all end groups upon a single triggering event in the dendritic core.

Authors:  Franciscus M H de Groot; Carsten Albrecht; Ralph Koekkoek; Patrick H Beusker; Hans W Scheeren
Journal:  Angew Chem Int Ed Engl       Date:  2003-09-29       Impact factor: 15.336

2.  Self-immolative dendrimers.

Authors:  Roey J Amir; Neta Pessah; Marina Shamis; Doron Shabat
Journal:  Angew Chem Int Ed Engl       Date:  2003-09-29       Impact factor: 15.336

3.  Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages.

Authors:  Wassana Yeeprae; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  J Control Release       Date:  2006-05-09       Impact factor: 9.776

4.  Hydrophobically modified dendrons: developing structure-activity relationships for DNA binding and gene transfection.

Authors:  Simon P Jones; Nathan P Gabrielson; Chun-Ho Wong; Hak-Fun Chow; Daniel W Pack; Paola Posocco; Maurizio Fermeglia; Sabrina Pricl; David K Smith
Journal:  Mol Pharm       Date:  2011-02-18       Impact factor: 4.939

Review 5.  Dendrimer toxicity: Let's meet the challenge.

Authors:  Keerti Jain; Prashant Kesharwani; Umesh Gupta; N K Jain
Journal:  Int J Pharm       Date:  2010-04-28       Impact factor: 5.875

6.  PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery.

Authors:  Quan Yuan; W Andrew Yeudall; Hu Yang
Journal:  Biomacromolecules       Date:  2010-08-09       Impact factor: 6.988

7.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

Authors:  István J Majoros; Andrzej Myc; Thommey Thomas; Chandan B Mehta; James R Baker
Journal:  Biomacromolecules       Date:  2006-02       Impact factor: 6.988

9.  Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.

Authors:  Pankaj V Paranjpe; Yu Chen; Vladyslav Kholodovych; William Welsh; Stanley Stein; Patrick J Sinko
Journal:  J Control Release       Date:  2004-11-24       Impact factor: 9.776

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  7 in total

1.  Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics.

Authors:  Abul K Azad; Murugesan V S Rajaram; Larry S Schlesinger
Journal:  J Cytol Mol Biol       Date:  2014-01-10

Review 2.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

Review 3.  Targeting the C-type lectins-mediated host-pathogen interactions with dextran.

Authors:  Sergey Pustylnikov; Divya Sagar; Pooja Jain; Zafar K Khan
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

4.  Specifically targeted delivery of protein to phagocytic macrophages.

Authors:  Min Yu; Zeming Chen; Wenjun Guo; Jin Wang; Yupeng Feng; Xiuqi Kong; Zhangyong Hong
Journal:  Int J Nanomedicine       Date:  2015-03-04

5.  A combined "eat me/don't eat me" strategy based on extracellular vesicles for anticancer nanomedicine.

Authors:  Zakia Belhadj; Bing He; Hailiang Deng; Siyang Song; Hua Zhang; Xueqing Wang; Wenbing Dai; Qiang Zhang
Journal:  J Extracell Vesicles       Date:  2020-08-19

6.  Multistage rocket: integrational design of a prodrug-based siRNA delivery system with sequential release for enhanced antitumor efficacy.

Authors:  Qian Jiang; Xiaobing Chen; Hong Liang; Yu Nie; Rongrong Jin; Matthias Barz; Dong Yue; Zhongwei Gu
Journal:  Nanoscale Adv       Date:  2018-10-20

7.  Enhancing Macrophage Drug Delivery Efficiency via Co-Localization of Cells and Drug-Loaded Microcarriers in 3D Resonant Ultrasound Field.

Authors:  Yu-Hsiang Lee; Zhen-Yu Wu
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.